PI
AUPH icon

PEAK6 Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

PEAK6 Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-110,600
Closed -$994K – 4016
2023
Q4 		$994K Hold
110,600
– – ﹤0.01% 2096
2023
Q3 		$859K Hold
110,600
– – ﹤0.01% 1959
2023
Q2 		$1.07M Hold
110,600
– – ﹤0.01% 1672
2023
Q1 		$1.21M Hold
110,600
– – 0.01% 1688
2022
Q4 		$478K Hold
110,600
– – ﹤0.01% 2561
2022
Q3 		$832K Sell
110,600
-110,600
-50% -$957K ﹤0.01% 2380
2022
Q2 		$2.18M Buy
221,200
+110,600
+100% +$1.24M ﹤0.01% 2237
2022
Q1 		$1.37M Hold
110,600
– – ﹤0.01% 2201
2021
Q4 		$2.53M Buy
+110,600
New +$2.62M 0.01% 1669

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's AUPH Position: Q1 2024 in Review

PEAK6 Investments sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 72,239 shares — an estimated $649K sold.

PEAK6 Investments first reported a position in AUPH in Q4 2021 and held it in 9 quarters. The position peaked at $851K in Q2 2022. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • PEAK6 Investments reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 72,239 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $649K.
  • PEAK6 Investments first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 9 quarters.
  • PEAK6 Investments's Aurinia Pharmaceuticals position peaked at $851K in Q2 2022.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.